Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-16 Sale |
2021-02-18 9:00 pm |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
2,524 | $85 | $214,540 | 198,976 (Direct) |
View |
| 2020-06-02 Sale |
2020-06-04 6:40 pm |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
25,000 | $65 | $1,625,023 | 219,500 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-25 4:10 pm |
N/A 2035-02-21 |
Inhibikase Therapeutics Inc. | IKT | Aurentz Vincent Director |
134,427 | $0 | 134,427 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:10 pm |
N/A 2034-05-22 |
Longboard Pharmaceuticals Inc. | LBPH | Aurentz Vincent Director |
22,500 | $0 | 22,500 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-26 4:10 pm |
N/A 2033-05-24 |
Longboard Pharmaceuticals Inc. | LBPH | Aurentz Vincent Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-31 08:24 am |
N/A 2032-05-23 |
Longboard Pharmaceuticals Inc. | LBPH | Aurentz Vincent Director |
12,367 | $0 | 12,367 (Direct) |
View |
| 2022-03-11 Other |
2022-03-11 4:07 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
55,964 | $0 | 55,964 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:59 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
21,462 | $0 | 55,122 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-14 7:59 pm |
N/A 2031-09-13 |
Longboard Pharmaceuticals Inc. | LBPH | Aurentz Vincent Director |
19,581 | $0 | 19,581 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 9:35 pm |
N/A 2028-03-01 |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
60,710 | $0 | 87,710 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 9:00 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
24 | $35.6 | 198,976 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 9:00 pm |
N/A 2024-02-13 |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
2,524 | $0 | 198,976 (Direct) |
View |
| 2021-02-16 Exercise |
2021-02-18 9:00 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
2,500 | $14.6 | 198,976 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 9:18 pm |
N/A 2022-01-03 |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
18,000 | $0 | 27,000 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-30 4:00 pm |
N/A 2022-01-03 |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
9,000 | $0 | 27,000 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 6:40 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
10,000 | $17.1 | 219,500 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 6:40 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
5,000 | $35.6 | 219,500 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 6:40 pm |
N/A 2023-08-15 |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
25,000 | $0 | 219,500 (Direct) |
View |
| 2020-06-02 Exercise |
2020-06-04 6:40 pm |
N/A N/A |
ARENA PHARMACEUTICALS INC | ARNA | Aurentz Vincent Executive VP and CBO |
10,000 | $14.6 | 219,500 (Direct) |
View |